These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28070870)

  • 1. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease.
    Checchia PA; Paes B; Bont L; Manzoni P; Simões EA; Fauroux B; Figueras-Aloy J; Carbonell-Estrany X
    Infect Dis Ther; 2017 Mar; 6(1):37-56. PubMed ID: 28070870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease.
    Paes B; Fauroux B; Figueras-Aloy J; Bont L; Checchia PA; Simões EA; Manzoni P; Carbonell-Estrany X
    Infect Dis Ther; 2016 Dec; 5(4):453-471. PubMed ID: 27864751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries.
    Bont L; Checchia PA; Fauroux B; Figueras-Aloy J; Manzoni P; Paes B; Simões EA; Carbonell-Estrany X
    Infect Dis Ther; 2016 Sep; 5(3):271-98. PubMed ID: 27480325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.
    Figueras-Aloy J; Manzoni P; Paes B; Simões EA; Bont L; Checchia PA; Fauroux B; Carbonell-Estrany X
    Infect Dis Ther; 2016 Dec; 5(4):417-452. PubMed ID: 27628014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases.
    Manzoni P; Figueras-Aloy J; Simões EAF; Checchia PA; Fauroux B; Bont L; Paes B; Carbonell-Estrany X
    Infect Dis Ther; 2017 Sep; 6(3):383-411. PubMed ID: 28653300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children.
    Simões EAF; Bont L; Manzoni P; Fauroux B; Paes B; Figueras-Aloy J; Checchia PA; Carbonell-Estrany X
    Infect Dis Ther; 2018 Mar; 7(1):87-120. PubMed ID: 29470837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.
    Fauroux B; Simões EAF; Checchia PA; Paes B; Figueras-Aloy J; Manzoni P; Bont L; Carbonell-Estrany X
    Infect Dis Ther; 2017 Jun; 6(2):173-197. PubMed ID: 28357706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.
    Chaw PS; Wong SWL; Cunningham S; Campbell H; Mikolajczyk R; Nair H;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S613-S619. PubMed ID: 31599958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palivizumab prophylaxis against respiratory syncytial virus infection in patients younger than 2 years of age with congenital heart disease.
    Mohammed MHA; Agouba R; Obaidy IE; Alhabshan F; Abu-Sulaiman R
    Ann Saudi Med; 2021; 41(1):31-35. PubMed ID: 33550912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey.
    Jung JW
    Korean J Pediatr; 2011 May; 54(5):192-6. PubMed ID: 21829409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical burden of severe respiratory syncytial virus infection during the first 2 years of life in children born between 2000 and 2011 in Scotland.
    Thwaites R; Buchan S; Fullarton J; Morris C; Grubb E; Rodgers-Gray B; Coutts J
    Eur J Pediatr; 2020 May; 179(5):791-799. PubMed ID: 31912234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses.
    Friedman D; Fryzek J; Jiang X; Bloomfield A; Ambrose CS; Wong PC
    PLoS One; 2017; 12(3):e0172512. PubMed ID: 28253361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Respiratory Syncytial Virus Infection in Cyanotic Congenital Heart Disease in a Subtropical Area.
    Chiu SN; Shao PL; Chen HC; Lin MT; Huang LM; Kao FY; Huang SK; Wang JK; Wu MH
    J Pediatr; 2016 Apr; 171():25-30.e1. PubMed ID: 26822618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
    Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D
    Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease.
    Cabalka AK
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S41-5. PubMed ID: 14730269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group.
    Simoes EA; Sondheimer HM; Top FH; Meissner HC; Welliver RC; Kramer AA; Groothuis JR
    J Pediatr; 1998 Oct; 133(4):492-9. PubMed ID: 9787686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus prophylaxis in infants with congenital airway anomalies compared to standard indications and complex medical disorders.
    Paes B; Kim D; Saleem M; Wong S; Mitchell I; Lanctot KL;
    Eur J Pediatr; 2019 Mar; 178(3):377-385. PubMed ID: 30610419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005-2017.
    Kim D; Saleem M; Paes B; Mitchell I; Lanctôt KL
    Clin Infect Dis; 2019 Aug; 69(6):980-986. PubMed ID: 30517603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization due to respiratory syncytial virus infection in patients under 2 years of age with hemodynamically significant congenital heart disease.
    Andres S; Bauer G; Rodríguez S; Novali L; Micheli D; Fariña D
    J Pediatr (Rio J); 2012 May; 88(3):246-52. PubMed ID: 22718202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.
    Wang D; Cummins C; Bayliss S; Sandercock J; Burls A
    Health Technol Assess; 2008 Dec; 12(36):iii, ix-x, 1-86. PubMed ID: 19049692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.